06-19-2025  3:24 pm   •   PDX and SEA Weather

  • 1
  • 2
  • 3
  • 4

NORTHWEST NEWS

During Record Eviction Rates, Advocates Decry Possible Slashes to Eviction Prevention

Pulling support will fuel homelessness crisis, advocates warn state leaders.

Juneteenth 2025 Celebrations in Portland and Seattle

Juneteenth is a young federal holiday, but the Black day of independence has been observed since June 19, 1865.

City Council Approves and Increases Central Albina Settlement

Black residents who were forcibly relocated for Emanuel Hospital expansion that never happened, and their descendants, sued over loss of property, wealth and community.

VanPort Mosaic Festival Fights Cultural Amnesia

Two-week event honors survivors of VanPort flood, their descendants and survivors of Japanese Internment in annual festival.

NEWS BRIEFS

Emmy-winning Journalist Launches Juneteenth Series.

L.A. Times Columnist/ABC News Contributor speaks w/ Big Sean, Ledisi, more. ...

Former Motel 6 to Open as Delta Park Motel Shelter in North Portland

New shelter will provide 24/7 wrap-around services for unhoused neighbors ...

Oregon Housing and Community Services Awards $8.7 Million in Down Payment and Home Repair for Veterans 

Eligible veterans and their families at or below 100% of area median income can qualify ...

Upcoming Virtual Meeting to Shape Oregon Civil Rights Agenda

Members of the public can participate in the open comment period at the end of the meeting, providing an opportunity for local voices...

Oregon in Multi-State Legal Fight to Protect Genetic Information in 23andMe Bankruptcy Case

AG Rayfield: People did not submit their personal data to 23andMe thinking their genetic blueprint would be sold off to the highest...

OPINION

SB 686 Will Support the Black Press

Oregon State Senator Lew Frederick brings attention to the fact that Big Tech corporations like Google and Facebook are using AI to scrape local news content and sell advertising on their platforms, completely bypassing local news sites like The...

Policymakers Should Support Patients With Chronic Conditions

As it exists today, 340B too often serves institutional financial gain rather than directly benefiting patients, leaving patients to ask “What about me?” ...

The Skanner News: Half a Century of Reporting on How Black Lives Matter

Publishing in one of the whitest cities in America – long before George Floyd ...

Cuts to Minority Business Development Agency Leaves 3 Staff

6B CDFI affordable capital for local investment also at risk ...

AFRICAN AMERICANS IN THE NEWS

ENTERTAINMENT

U.S. & WORLD NEWS

Malcom Ritter AP Science Writer


Dr. Anthony Fauci, director of
the National Institute of Allergy
and Infectious Diseases

NEW YORK (AP) -- As scientists struggle to find a vaccine to prevent infection with the AIDS virus, a study in mice suggests hope for a new approach - one that doctors now want to test in people.

The treated mice in the study appeared to have 100 percent protection against HIV. That doesn't mean the strategy will work in people. But several experts were impressed.

"This is a very important paper (about) a very creative idea," says the government's AIDS chief, Dr. Anthony Fauci. He didn't take part in the research.

The new study involved injecting mice with a protective gene, an idea that's been tested against HIV infection in animals for a decade.

In the nearly 30 years since HIV was identified, scientists haven't been able to find a vaccine that is broadly effective. One boost came in 2009, when a large study in Thailand showed that an experimental vaccine protected about a third of recipients against infection. That's not good enough for general use, but researchers are now trying to improve it.

Researchers reported the new results in mice online Wednesday in the journal Nature. They hope to test the approach in people in a couple of years. Another research team reported similar success in monkeys in 2009 and hopes to start human tests even sooner.

A traditional vaccine works by masquerading as a germ, training the body's immune system to build specific defenses in case the real germ shows up. Those defenses are generally antibodies, which are proteins in the blood that have just the right shape to grab onto parts of an invading virus. Once that happens, the virus can't establish a lasting infection and is cleared from the body.

Scientists have identified antibodies that neutralize a wide range of HIV strains, but they've had trouble getting people's immune systems to create those antibodies with a vaccine.

The gene-injection goal is straightforward. Rather than trying to train a person's immune system to devise effective antibodies, why not just give a person genes for those proteins? The genes can slip into cells in muscle or some other tissue and make them pump out lots of the antibodies.

The mouse work is reported by David Baltimore and colleagues at the California Institute of Technology.

Ordinary mice don't get infected with HIV, which attacks the immune system. So the research used mice that carried human immune system cells.

Baltimore's team used a harmless virus to carry an antibody gene and injected it once into a leg muscle. The researchers found that the mice made high levels of the antibody for more than a year. The results suggest lifetime protection for a mouse, Baltimore said, although "we simply don't know what will happen in people."

Even when the mice were injected with very high doses of HIV, they didn't show the loss of certain blood cells that results from HIV infection. Baltimore said researchers couldn't completely rule out the possibility of infection, but that their tests found no evidence of it. He said a few hundred mice appeared to be protected.

The work was funded by the federal government and the Bill and Melinda Gates Foundation. Baltimore said his lab has filed for patents.

"I think it's great," said Dr. Philip R. Johnson of the Children's Hospital of Philadelphia, who reported similar results in monkeys in 2009. "It provides additional evidence this is a concept that's worth moving forward."

Johnson said he has discussed doing a human trial with federal regulators and is preparing an application for permission to go ahead. If all goes well, a preliminary experiment to test the safety of the approach might begin in about a year, he said. Baltimore said his group is also planning human experiments that he hopes will start in the next couple years.

Fauci, who is director of the National Institute of Allergy and Infectious Diseases, cautioned that mouse results don't always pan out in human studies. He also said both the gene approach and standard vaccines should be pursued because it's not clear which will work better.

"We're still in the discovery stage of both of them," he said.

Dr. Harris Goldstein, director of the Einstein-Montefiore Center for AIDS Research in New York, who has done similar research in mice, called Baltimore's result a significant advance if it works in humans because it shows a single injection produces high levels of antibodies for a long time.

It might lead not only to preventing infection, but also a treatment for infected people, he said. If it allowed people with HIV to stop or reduce their medications even for temporary periods, they could avoid the inconvenience and side effects of the drugs, he said.

---

Online:

Nature: http://www.nature.com/nature

---

Malcolm Ritter can be followed at http://twitter.com/malcolmritter .

© 2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.

theskanner50yrs 250x300